Raymond James analyst Jayson Bedford downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Market Perform.
Centene Q3 EPS $1.30 Beats $1.24 Estimate, Sales $35.87B Beat $35.47B Estimate
Centene (NYSE:CNC) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $1.24 by 4.84 percent. This is a 3.17 percent increase over earnings of $1.26 per share from the same period
